CAPTRUST FINANCIAL ADVISORS - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$612,321
-12.1%
19,365
+13.4%
0.00%
-33.3%
Q2 2023$696,400
+39.2%
17,077
+27.2%
0.00%
+50.0%
Q1 2023$500,238
+1.4%
13,422
-5.1%
0.00%0.0%
Q4 2022$493,240
-38.1%
14,137
-0.7%
0.00%
-60.0%
Q3 2022$797,000
+47.0%
14,240
+36.0%
0.01%
+66.7%
Q2 2022$542,000
-40.9%
10,470
-17.0%
0.00%
-50.0%
Q1 2022$917,000
-62.7%
12,615
-39.3%
0.01%
-64.7%
Q4 2021$2,456,000
+6.8%
20,770
+21.1%
0.02%
-10.5%
Q3 2021$2,300,000
-4.0%
17,145
+15.9%
0.02%
-13.6%
Q2 2021$2,395,000
+95.8%
14,794
-2.9%
0.02%
+69.2%
Q1 2021$1,223,000
+606.9%
15,243
+379.6%
0.01%
+550.0%
Q4 2020$173,000
+1822.2%
3,178
+601.5%
0.00%
Q3 2020$9,000
+800.0%
453
+754.7%
0.00%
Q2 2020$1,000
-85.7%
53
-79.4%
0.00%
Q3 2018$7,000
-30.0%
257
-31.5%
0.00%
-100.0%
Q2 2018$10,0003750.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Discovery Value Fund 572,950$19,990,2265.79%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$39,952,2255.34%
MPM BioImpact LLC 455,238$15,883,2544.12%
ARK Investment Management 9,420,782$328,691,0842.85%
Atlas Venture Associates IX, LLC 10,000$348,9001.74%
Ghisallo Capital Management LLC 250,000$8,722,5001.55%
Nikko Asset Management Americas, Inc. 2,976,002$103,743,4301.49%
Prosight Management, LP 72,116$2,516,1271.37%
Rokos Capital Management LLP 826,063$28,391,7851.24%
Elmwood Wealth Management, Inc. 67,899$2,368,9961.18%
View complete list of INTELLIA THERAPEUTICS INC shareholders